Prevalence and incidence of infections among blood donors in Astana
- Authors: Skorikova S.V.1, Burkitbaev Z.K.1, Savchuk T.N.1, Zhiburt E.B.2
-
Affiliations:
- Research and Production Center of Transfusiology of Republic of Kazakhstan
- Pirogov National Medical Surgical Center, Ministry of Health of the Russian Federation
- Issue: Vol 60, No 1 (2015)
- Pages: 34-36
- Section: ORIGINAL RESEARCH
- Submitted: 09.07.2020
- Accepted: 09.07.2020
- Published: 28.02.2015
- URL: https://virusjour.crie.ru/jour/article/view/313
- ID: 313
Cite item
Full Text
Abstract
The prevalence and incidence of infections among 28,248 blood donors in Astana in 2012 was determined. The estimated residual risk of the transfusion infection was as follows: for HIV - 1,2, HCV - 137,7, HBV - 125,4 per 1 million donations. High risk of transfusion infection with HIV, hepatitis B, and C stimulates the active implementation of the measures for increasing the safety of blood: the selection of donors, increasing the sensitivity of infections screening methods, inactivation of pathogens in blood components and transfusion management appointment at the clinic.
Keywords
About the authors
S. V. Skorikova
Research and Production Center of Transfusiology of Republic of Kazakhstan
Author for correspondence.
Email: tarkiff@mail.ru
Svetlana Skorikova
010000, Astana
KazakhstanZh. K. Burkitbaev
Research and Production Center of Transfusiology of Republic of Kazakhstan
Email: fake@neicon.ru
010000, Astana Kazakhstan
T. N. Savchuk
Research and Production Center of Transfusiology of Republic of Kazakhstan
Email: fake@neicon.ru
010000, Astana Kazakhstan
E. B. Zhiburt
Pirogov National Medical Surgical Center, Ministry of Health of the Russian Federation
Email: fake@neicon.ru
105203, Moscow Russian Federation
References
- Жибурт Е.Б., Бельгесов Н.В., Ващенко Т.Н., Бондаренко И.Г., Токмаков В.С., Василюк В.Б. Аланинаминотрансфераза – суррогатный маркер вирусного гепатита. Вопросы вирусологии. 1995; 40 (1): 25–7.
- Жибурт Е.Б. Повышение вирусной безопасности препаратов крови. Вопросы вирусологии. 2004; 49 (4): 46–8.
- Жибурт Е.Б. Аланинаминотрансфераза – суррогатный маркер вирусного гепатита. Вопросы вирусологии. 2005; 50 (6): 18–20.
- Жибурт Е.Б., Губанова М.Н., Клюева Е.А., Коденев А.Т., Шестаков Е.А. Особенности национального скрининга маркеров инфекций в донорской крови. Вестник Росздравнадзора. 2010; 1: 75–9.
- Зубкова Н.В., Филатова Е.В., Зубов С.В. Серологические и молекулярно-генетические маркеры вируса гепатита С у инфицированных доноров. Вопросы вирусологии. 2010; 55 (5): 34–6.
- Enticott J.C., Kandane-Rathnayake R.K. Prevalence versus incidence. Transfusion. 2012; 52 (9): 1868–70.
- Schreiber G.B., Busch M.P., Kleinman S.H., Korelitz J.J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N. Engl. J. Med. 1996; 334 (26): 1685–90.
- Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC
- Жибурт Е.Б., Караваев А.В., Вайсман Д.А., Мадзаев С.Р. Особенности национальной оценки риска передачи инфекций при переливании крови. Вестник Росздравнадзора. 2013: 1: 75–7.
- de Almeida-Neto C., Sabino E.C., Liu J., Blatyta P.F., MendroneJunior A., Salles N.A. et al. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion. 2013; 53 (4): 827–34.
- Sanquin Blood Supply. Available at: http://www.sanquin.nl/en/ (accessed 16th of July 2013).
- Скрининг донорской крови на гемотрансмиссивные инфекции. Рекомендации Всемирной организации здравоохранения. Женева: ВОЗ; 2010.
- Busch M.P., Glynn S.A., Stramer S.L., Strong D.M., Caglioti S., Wright D.J. et al. A new strategy for estimating risks of transfusiontransmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005; 45 (2): 254–64.
- Куликов С. М., Гармаева Т.Ц., Зингерман Б.В., Филатов Ф.П., Судариков А.Б., Михайлова Е.А. и др. Вирусная безопасность гемотрансфузии и методы ее оценки. Гематология и трансфузиология. 2011; 53 (4): 3–5.